Balancing clinical trial transparency with privacy can be difficult. How can you make patient-level data available while still protecting patient privacy? Join Darshan as he talks with transparency expert Nirpal Virdee about the tension between...
Creating a transparency plan for your company can be a difficult undertaking. What are five steps to take when creating a transparency program for the first time? Join Darshan Kulkarni as he talks with guest Major Hoffman about the basics of setting...
The COVID-19 pandemic has rapidly transformed the clinical trials landscape. What is happening to data as clinical trials become increasingly decentralized? Join Darshan Kulkarni as he talks with guests Craig Lipset, Artem Andrianov and Moe...
Although companies often need to develop clinical trial transparency programs to meet regulations, it can be unclear where to start. How should you create a compliant transparency program? Join Darshan Kulkarni as he talks with guest Major Hoffman...
Clinical studies have become increasingly virtual because of COVID-19. How has this affected the way the FDA inspects clinical trials? Join Darshan Kulkarni as he talks with former FDA auditor Patrick Stone about his experience investigating sites...
Clinical study transparency programs are necessary for companies looking to disclose data and fully comply with state and federal regulations. Why else should your company create a transparency program? Join Darshan Kulkarni as he talks with guest...